BrainAurora
-

BrainAurora Medical Technology H1 2026 Results Show Revenue Growth Amid Persistent Losses
BrainAurora Medical Technology reported a 19.8% revenue increase in H1 2026, yet net losses widened to ¥134 million, pressuring the firm’s stock valuation.
